Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
buyouts
Pharma
Cycle's 2nd hostile takeover bid in 5 months rejected by Vanda
For the second time in five months, Vanda Pharmaceuticals has rejected an $8-per-share takeover bid from Cycle Pharmaceuticals of England.
Kevin Dunleavy
Oct 14, 2024 3:18pm
Sanofi courts offers for its consumer health business: Bloomberg
Sep 25, 2024 12:05pm
Agilent will pay $925M to acquire specialty CDMO Biovectra
Jul 22, 2024 11:01am
Former FTC director weighs in on $16.5B Novo-Catalent deal
Jul 19, 2024 9:27am
Sanofi asks for private equity bids for consumer unit: report
Jun 26, 2024 8:46am
FTC to review Novo Holdings' Catalent buyout for another month
May 3, 2024 2:00pm
